Milwaukee Syndrome
Milwaukee shoulder syndrome (MSS) (apatite-associated destructive arthritis/Basic calcium phosphate (BCP) crystal arthritis/rapid destructive arthritis of the shoulder is a rare rheumatological condition similar to pseudogout, associated with periarticular or intra-articular deposition of hydroxyapatite or basic calcium phosphate (BCP) crystals.
Causes of Milwaukee Syndrome
Hydroyapatite crystal deposition in the joint causes the release of collagenases, serine proteases, elastases, and interleukin-1. This leads to acute and rapid decline in joint function and degradation of joint anatomy. Subsequently, disruption of the rotator cuff ensues.
Symptoms of Milwaukee Syndrome
Limited active range of motion, usually unrestricted passive range of movement (early)
Joint pain
Joint inflammation and tenderness
Synovial hemorrhagic effusion/hematoma
Radiologic positive findings
Hydroxyapatite crystals in synovial fluid
Diagnosis of Milwaukee Syndrome
Diagnosis is made with arthrocentesis and Alizarin Red staining along with clinical symptoms.
X-rays, arthrography, ultrasonography, CT imaging and MRI imaging are also helpful in diagnosing this condition
Treatment of Milwaukee Syndrome
Treatment may include the prescription of one or more of the following:
Non-steroidal anti-inflammatory drugs (NSAIDs)
Intra-articular steroids
Physical therapy
Partial or complete arthroplasty